{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T13:34:47Z","timestamp":1763559287658,"version":"3.45.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Intramural Research Program, NCI, NIH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Incidence and mortality rates for endometrial cancer are rising. We need to better understand the etiology of this disease and identify new risk factors. We examined whether common genital infections are associated with endometrial cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using serum samples from The Polish Endometrial Cancer Study (443 cases, 443 controls), we measured antibodies against microbial antigens with a multiplex fluorescent bead-based assay. We estimated adjusted odds ratios (OR) and 95% confidence intervals (CI), comparing women with positive versus negative serology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Most antibodies were not associated with endometrial cancer overall, but seropositivity for\n                      <jats:italic>Herpes simplex virus 2<\/jats:italic>\n                      was associated with low-grade tumors (OR 1.43 CI 1.02, 2.00). While increased risks for type II, but not type I tumors, were consistently indicated for multiple\n                      <jats:italic>Chlamydia trachomatis<\/jats:italic>\n                      antigens, most estimates did not reach statistical significance (e.g., Pgp3 seropositivity and type I cancers: OR 0.97 CI 0.73, 1.31; and type II: OR 2.96 CI 0.85, 10.31; heterogeneity\n                      <jats:italic>p<\/jats:italic>\n                      -value\u2009=\u20090.03). The strongest associations for type II tumors were observed with seropositivity for\n                      <jats:italic>Chlamydial<\/jats:italic>\n                      stress response proteins.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Reproductive tract infections may increase risk for endometrial cancer, but the biologic mechanisms are likely both microbe- and histology-specific. Some\n                      <jats:italic>C. trachomatis<\/jats:italic>\n                      infections may be a risk factor for type II endometrial cancers. Given that so few risk factors for type II endometrial cancers are identified, infection-related mechanisms of carcinogenesis in the endometrium merit continued investigation.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10552-025-02080-6","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:33:47Z","timestamp":1760549627000},"page":"2015-2022","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating biomarkers of infection and endometrial cancer risk"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2431-2079","authenticated-orcid":false,"given":"Kara A.","family":"Michels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rima","family":"Jeske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolanta","family":"Lissowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Pep\u0142o\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Waterboer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britton","family":"Trabert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"unstructured":"Ervik M, Lam F, Laversanne M, Ferlay J, Bray F. Global Cancer Observatory: Cancer Over Time. \"Estimated annual percentage change of age-standardized rates per 100 000: uterine corpus cancer, incidence, females (Multiple regions, including Poland and USA)\". International Agency for Research on Cancer; 2022. Accessed August 2022. https:\/\/gco.iarc.fr\/overtime\/en","key":"2080_CR1"},{"issue":"7","key":"2080_CR2","doi-asserted-by":"publisher","first-page":"e268","DOI":"10.1016\/S1470-2045(13)70591-6","volume":"15","author":"R Murali","year":"2014","unstructured":"Murali R, Soslow RA, Weigelt B (2014) Classification of endometrial carcinoma: more than two types. Lancet Oncol 15(7):e268\u2013e278","journal-title":"Lancet Oncol"},{"issue":"9","key":"2080_CR3","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1001\/jamainternmed.2018.2820","volume":"178","author":"MA Clarke","year":"2018","unstructured":"Clarke MA, Long BJ, Del Mar MA, Arbyn M, Bakkum-Gamez JN, Wentzensen N (2018) Association of endometrial cancer risk with postmenopausal bleeding in women: a systematic review and meta-analysis. JAMA Intern Med 178(9):1210\u20131222","journal-title":"JAMA Intern Med"},{"key":"2080_CR4","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1200\/JCO.19.00151","volume":"37","author":"MA Clarke","year":"2019","unstructured":"Clarke MA, Devesa SS, Harvey SV, Wentzensen N (2019) Hysterectomy-corrected uterine corpus cancer incidence trends and differences in relative survival reveal racial disparities and rising rates of nonendometrioid cancers. J Clin Oncol. 37:1895\u2013908","journal-title":"J Clin Oncol."},{"issue":"20","key":"2080_CR5","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","volume":"31","author":"VW Setiawan","year":"2013","unstructured":"Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang YB, Wolk A, Wentzensen N, Weiss NS, Webb PM, van den Brandt PA, van de Vijver K, Thompson PJ, Strom BL, Spurdle AB, Soslow RA, Shu XO, Schairer C, Sacerdote C, Rohan TE, Robien K, Risch HA, Ricceri F, Rebbeck TR, Rastogi R, Prescott J, Polidoro S, Park Y, Olson SH, Moysich KB, Miller AB, McCullough ML, Matsuno RK, Magliocco AM, Lurie G, Lu L, Lissowska J, Liang X, Lacey JV Jr, Kolonel LN, Henderson BE, Hankinson SE, H\u00e5kansson N, Goodman MT, Gaudet MM, Garcia-Closas M, Friedenreich CM, Freudenheim JL, Doherty J, De Vivo I, Courneya KS, Cook LS, Chen C, Cerhan JR, Cai H, Brinton LA, Bernstein L, Anderson KE, Anton-Culver H, Schouten LJ, Horn-Ross PL (2013) Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 31(20):2607\u20132618","journal-title":"J Clin Oncol"},{"issue":"2","key":"2080_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ygyno.2013.02.023","volume":"129","author":"LA Brinton","year":"2013","unstructured":"Brinton LA, Felix AS, McMeekin DS, Creasman WT, Sherman ME, Mutch D, Cohn DE, Walker JL, Moore RG, Downs LS, Soslow RA, Zaino R (2013) Etiologic heterogeneity in endometrial cancer: evidence from a gynecologic oncology group trial. Gynecol Oncol 129(2):277\u2013284","journal-title":"Gynecol Oncol"},{"issue":"2","key":"2080_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/jnci\/djy084","volume":"111","author":"B Trabert","year":"2019","unstructured":"Trabert B, Waterboer T, Idahl A, Brenner N, Brinton LA, Butt J, Coburn SB, Hartge P, Hufnagel K, Inturrisi F, Lissowska J, Mentzer A, Peplonska B, Sherman ME, Wills GS, Woodhall SC, Pawlita M, Wentzensen N (2019) Antibodies against chlamydia trachomatis and ovarian cancer risk in two independent populations. J Natl Cancer Inst 111(2):129\u2013136","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"2080_CR8","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1086\/368380","volume":"187","author":"RB Ness","year":"2003","unstructured":"Ness RB, Goodman MT, Shen C, Brunham RC (2003) Serologic evidence of past infection with Chlamydia trachomatis, in relation to ovarian cancer. J Infect Dis 187(7):1147\u20131152","journal-title":"J Infect Dis"},{"key":"2080_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/824627","author":"A Idahl","year":"2011","unstructured":"Idahl A, Lundin E, Jurstrand M, Kumlin U, Elgh F, Ohlson N, Ottander U (2011) Chlamydia trachomatis and Mycoplasma genitalium plasma antibodies in relation to epithelial ovarian tumors. Infect Dis Obstet Gynecol. https:\/\/doi.org\/10.1155\/2011\/824627","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"9","key":"2080_CR10","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1007\/s10096-012-1570-5","volume":"31","author":"S Shanmughapriya","year":"2012","unstructured":"Shanmughapriya S, SenthilKumar G, Vinodhini K, Das BC, Vasanthi N, Natarajaseenivasan K (2012) Viral and bacterial aetiologies of epithelial ovarian cancer. Eur J Clin Microbiol Infect Dis 31(9):2311\u20132317","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"2080_CR11","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/s41416-019-0422-9","volume":"120","author":"RT Fortner","year":"2019","unstructured":"Fortner RT, Terry KL, Bender N, Brenner N, Hufnagel K, Butt J, Waterboer T, Tworoger SS (2019) Sexually transmitted infections and risk of epithelial ovarian cancer: results from the Nurses\u2019 Health Studies. Br J Cancer 120(8):855\u2013860","journal-title":"Br J Cancer"},{"issue":"9","key":"2080_CR12","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/sj.bjc.6603731","volume":"96","author":"LA Brinton","year":"2007","unstructured":"Brinton LA, Sakoda LC, Lissowska J, Sherman ME, Chatterjee N, Peplonska B, Szeszenia-Dabrowska N, Zatonski W, Garcia-Closas M (2007) Reproductive risk factors for endometrial cancer among Polish women. Br J Cancer 96(9):1450\u20131456","journal-title":"Br J Cancer"},{"key":"2080_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1471-2407-7-60","volume":"7","author":"M Garcia-Closas","year":"2007","unstructured":"Garcia-Closas M, Brinton LA, Lissowska J, Richesson D, Sherman ME, Szeszenia-Dabrowska N, Peplonska B, Welch R, Yeager M, Zatonski W, Chanock SJ (2007) Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case\u2013control study. BMC Cancer 7:60","journal-title":"BMC Cancer"},{"issue":"4","key":"2080_CR14","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ejca.2009.11.015","volume":"46","author":"HP Yang","year":"2010","unstructured":"Yang HP, Brinton LA, Platz EA, Lissowska J, Lacey JV Jr., Sherman ME, Peplonska B, Garcia-Closas M (2010) Active and passive cigarette smoking and the risk of endometrial cancer in Poland. Eur J Cancer 46(4):690\u2013696","journal-title":"Eur J Cancer"},{"issue":"10","key":"2080_CR15","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1373\/clinchem.2005.052381","volume":"51","author":"T Waterboer","year":"2005","unstructured":"Waterboer T, Sehr P, Michael KM, Franceschi S, Nieland JD, Joos TO, Templin MF, Pawlita M (2005) Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem 51(10):1845\u20131853","journal-title":"Clin Chem"},{"issue":"12","key":"2080_CR16","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3390\/microorganisms7120703","volume":"7","author":"K Hufnagel","year":"2019","unstructured":"Hufnagel K, Hoenderboom B, Harmel C, Rohland JK, van Benthem BHB, Morr\u00e9 SA, Waterboer T (2019) Chlamydia trachomatis whole-proteome microarray analysis of the netherlands chlamydia cohort study. Microorganisms 7(12):703","journal-title":"Microorganisms"},{"issue":"2","key":"2080_CR17","first-page":"193","volume":"13","author":"P Draca","year":"1992","unstructured":"Draca P, Damjanovic J, Draca T, Vukovic V (1992) Viruses as possible etiological factors in human genital cancer. Eur J Gynaecol Oncol 13(2):193\u2013199","journal-title":"Eur J Gynaecol Oncol"},{"issue":"6","key":"2080_CR18","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrmicro.2016.30","volume":"14","author":"C Elwell","year":"2016","unstructured":"Elwell C, Mirrashidi K, Engel J (2016) Chlamydia cell biology and pathogenesis. Nat Rev Microbiol 14(6):385\u2013400","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"2080_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171551","volume":"12","author":"B Davies","year":"2017","unstructured":"Davies B, Turner KM, Leung S, Yu BN, Fr\u00f8lund M, Benfield T, Blanchard J, Westh H, Ward H (2017) Comparison of the population excess fraction of Chlamydia trachomatis infection on pelvic inflammatory disease at 12-months in the presence and absence of chlamydia testing and treatment: systematic review and retrospective cohort analysis. PLoS ONE 12(2):e0171551","journal-title":"PLoS ONE"},{"issue":"12 Suppl 2","key":"2080_CR20","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1093\/infdis\/jiab067","volume":"224","author":"CM Mitchell","year":"2021","unstructured":"Mitchell CM, Anyalechi GE, Cohen CR, Haggerty CL, Manhart LE, Hillier SL (2021) Etiology and diagnosis of pelvic inflammatory disease: looking beyond Gonorrhea and Chlamydia. J Infect Dis 224(12 Suppl 2):S29-s35","journal-title":"J Infect Dis"},{"key":"2080_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/ijgo.13066","volume":"149","author":"KK Sogaard","year":"2019","unstructured":"Sogaard KK, Leisner MZ, Laugesen K, Farkas DK, Karagas MR, Sorensen HT (2019) Pelvic inflammatory disease and risk of cancer: a nationwide cohort study. Int J Gynaecol Obstet 149:107","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"2080_CR22","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1186\/s12885-016-2857-1","volume":"16","author":"CC Shen","year":"2016","unstructured":"Shen CC, Hu LY, Yang AC, Chiang YY, Hung JH, Tsai SJ (2016) Risk of uterine, ovarian and breast cancer following pelvic inflammatory disease: a nationwide population-based retrospective cohort study. BMC Cancer 16(1):839","journal-title":"BMC Cancer"},{"issue":"Pt 9","key":"2080_CR23","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1099\/mic.0.030247-0","volume":"155","author":"JD Miller","year":"2009","unstructured":"Miller JD, Sal MS, Schell M, Whittimore JD, Raulston JE (2009) Chlamydia trachomatis YtgA is an iron-binding periplasmic protein induced by iron restriction. Microbiology (Reading) 155(Pt 9):2884\u20132894","journal-title":"Microbiology (Reading)"},{"issue":"1","key":"2080_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10096-016-2769-7","volume":"36","author":"K Hokynar","year":"2017","unstructured":"Hokynar K, Korhonen S, Norja P, Paavonen J, Puolakkainen M (2017) Antibody to Chlamydia trachomatis proteins, TroA and HtrA, as a biomarker for Chlamydia trachomatis infection. Eur J Clin Microbiol Infect Dis 36(1):49\u201356","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5389","key":"2080_CR25","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1126\/science.282.5389.754","volume":"282","author":"RS Stephens","year":"1998","unstructured":"Stephens RS, Kalman S, Lammel C, Fan J, Marathe R, Aravind L, Mitchell W, Olinger L, Tatusov RL, Zhao Q, Koonin EV, Davis RW (1998) Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science. 282(5389):754\u20139","journal-title":"Science."},{"issue":"9","key":"2080_CR26","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1128\/IAI.00377-16","volume":"84","author":"SP Ouellette","year":"2016","unstructured":"Ouellette SP, Rueden KJ, Rucks EA (2016) Tryptophan codon-dependent transcription in Chlamydia pneumoniae during gamma interferon-mediated tryptophan limitation. Infect Immun 84(9):2703\u20132713","journal-title":"Infect Immun"},{"issue":"1","key":"2080_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.micinf.2005.05.018","volume":"8","author":"A Polkinghorne","year":"2006","unstructured":"Polkinghorne A, Hogan RJ, Vaughan L, Summersgill JT, Timms P (2006) Differential expression of chlamydial signal transduction genes in normal and interferon gamma-induced persistent Chlamydophila pneumoniae infections. Microbes Infect 8(1):61\u201372","journal-title":"Microbes Infect"},{"issue":"9","key":"2080_CR28","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1073\/pnas.90.9.3998","volume":"90","author":"WL Beatty","year":"1993","unstructured":"Beatty WL, Byrne GI, Morrison RP (1993) Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci USA 90(9):3998\u20134002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"2080_CR29","doi-asserted-by":"publisher","first-page":"e1000552","DOI":"10.1371\/journal.ppat.1000552","volume":"5","author":"F Cappello","year":"2009","unstructured":"Cappello F, Conway de Macario E, Di Felice V, Zummo G, Macario AJ (2009) Chlamydia trachomatis infection and anti-Hsp60 immunity: the two sides of the coin. PLoS Pathog. 5(8):e1000552","journal-title":"PLoS Pathog."},{"issue":"6","key":"2080_CR30","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/clinids\/7.6.731","volume":"7","author":"AB MacDonald","year":"1985","unstructured":"MacDonald AB (1985) Antigens of Chlamydia trachomatis. Rev Infect Dis 7(6):731\u2013736","journal-title":"Rev Infect Dis"},{"issue":"4","key":"2080_CR31","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/infdis\/130.4.388","volume":"130","author":"SP Wang","year":"1974","unstructured":"Wang SP, Grayston JT (1974) Human serology in Chlamydia trachomatis infection with microimmunofluorescence. J Infect Dis 130(4):388\u2013397","journal-title":"J Infect Dis"},{"issue":"1","key":"2080_CR32","doi-asserted-by":"publisher","first-page":"7503","DOI":"10.1038\/s41598-018-25918-3","volume":"8","author":"K Hufnagel","year":"2018","unstructured":"Hufnagel K, Lueong S, Willhauck-Fleckenstein M, Hotz-Wagenblatt A, Miao B, Bauer A, Michel A, Butt J, Pawlita M, Hoheisel JD, Waterboer T (2018) Immunoprofiling of Chlamydia trachomatis using whole-proteome microarrays generated by on-chip in situ expression. Sci Rep 8(1):7503","journal-title":"Sci Rep"},{"key":"2080_CR33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.mimet.2018.02.017","volume":"147","author":"H Kaur","year":"2018","unstructured":"Kaur H, Dize L, Munoz B, Gaydos C, West SK (2018) Evaluation of the reproducibility of a serological test for antibodies to Chlamydia trachomatis pgp3: a potential surveillance tool for trachoma programs. J Microbiol Methods 147:56\u201358","journal-title":"J Microbiol Methods"},{"issue":"6","key":"2080_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.micres.2013.02.001","volume":"168","author":"R Ferreira","year":"2013","unstructured":"Ferreira R, Borges V, Nunes A, Borrego MJ, Gomes JP (2013) Assessment of the load and transcriptional dynamics of Chlamydia trachomatis plasmid according to strains\u2019 tissue tropism. Microbiol Res 168(6):333\u2013339","journal-title":"Microbiol Res"},{"issue":"3","key":"2080_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151497","volume":"11","author":"PJ Horner","year":"2016","unstructured":"Horner PJ, Wills GS, Righarts A, Vieira S, Kounali D, Samuel D, Winston A, Muir D, Dickson NP, McClure MO (2016) Chlamydia trachomatis Pgp3 antibody persists and correlates with self-reported infection and behavioural risks in a blinded cohort study. PLoS ONE 11(3):e0151497","journal-title":"PLoS ONE"},{"issue":"9","key":"2080_CR36","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/aje\/kwh101","volume":"159","author":"MS Pepe","year":"2004","unstructured":"Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P (2004) Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 159(9):882\u2013890","journal-title":"Am J Epidemiol"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-025-02080-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-025-02080-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-025-02080-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T13:31:15Z","timestamp":1763559075000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-025-02080-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2080"],"URL":"https:\/\/doi.org\/10.1007\/s10552-025-02080-6","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"type":"print","value":"0957-5243"},{"type":"electronic","value":"1573-7225"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors has conflicts to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}